During the week, veterinary professionals, retailers and rabbit owners will be encouraged by Burgess and campaign partners the RSPCA, RAWF, Wood Green, PDSA and Blue Cross to sign and share a pledge to move away from muesli on the website: http://www.rabbitawarenessweek.co.uk.
Alex Thorne at Burgess Pet Care, said: "Muesli should never be part of a rabbit’s diet but, sadly, a widespread lack of understanding and awareness around its risks means it’s often too easy for rabbit owners to make the wrong choice. Research continues to show that there is a lack of understanding around the correct nutritional needs of rabbits, and the continued feeding of muesli is a major outcome of that.
"Feeding rabbits muesli increases the risk of selective feeding. Just like children would typically pick sweet treats when faced with the choice between them or vegetables, rabbits will eat parts of the muesli mix that are high in starch and sugar, whilst leaving behind the more nutritious elements.
"We’re encouraging all rabbit lovers to get involved with this year’s campaign by visiting the Rabbit Awareness Week website and signing the ‘Move Away from Muesli’ pledge, before spreading the word amongst fellow rabbit owners. It’s our ambition to move as many rabbits away from muesli towards a good quality hay-based diet supplemented by a small portion of high-quality nuggets and a few fresh greens, which provides the nutrients rabbits need to be happy and healthy."
Burgess says there will also be campaign packs to help support practices in spreading the word, details of which will be available nearer the time.
Bordetella bronchiseptica is a clinically significant pathogen for canine infectious respiratory disease (CIRD), otherwise known as kennel cough, with 78.7% of dogs with acute respiratory signs testing positive for the bacteria1.
In the same study, 45.6% of clinically healthy dogs also tested positive for Bordetella bronchiseptica, illustrating that clinically healthy dogs can carry respiratory pathogens and could act as sources of infection for susceptible dogs1.
Administered via subcutaneous injection, Canigen Bb is an inactivated subunit vaccine which offers vets a new option when intra-nasal vaccination with a live aerosolised vaccine is not possible or preferred, for example when the dog is in contact with known immunocompromised individuals.
Licensed for use in dogs from 6 weeks of age, Canigen Bb extends protection against Bordetella bronchiseptica in dogs vaccinated with Canigen KC in the last 12 months for a further year with a single dose.
Canigen Bb is presented as a ready-to-use formula in a 10ml multi-dose bottle and can be stored at room temperature (2°C - 25°C) for up to 4 weeks once broached.
It can be administered concurrently (at the same time but separate injections) with Canigen DHP, Canigen DHPPi, Canigen Pi & Canigen Lepto 4.
Andrew Connolly, Marketing Director at Virbac, said: ‘It is our hope that Canigen Bb will increase the overall uptake of Bordetella bronchiseptica vaccination to provide increased protection against this widely prevalent and clinically significant disease’.
Reference
The new editorial team of Ed Hall, David Williams and Aarti Kathrani says the manual has been completely rewritten and reorganised to provide a current, well-structured overview of the main gastrointestinal diseases that challenge both clinical practitioners and academics.
The Manual is divided into four sections:
Diagnostic procedures and techniques: history taking, physical examination, clinical pathology, imaging and biopsy.
Diagnostic approaches to problems: diagnostic approach to complaints/problems affecting the GI tract, pancreas and liver.
Patient management: treatments available for GI, pancreatic and liver disease, including a chapter on fluid and nutritional therapy.
Diseases of specific systems/organs: conditions of organs of the GI tract, including pathophysiology, clinical signs, diagnosis, treatment and prognosis.
Ed Hall said: "The busy small animal practitioner is likely to see a dog or cat with GI signs most days and having this Manual as a resource should give them greater insight into the conditions they are treating and hopefully make their job more satisfying."
The BSAVA Manual of Canine and Feline Gastroenterology is available in a printed edition (£90; £60 to BSAVA members) and an online edition (£75 +VAT; £50 +VAT to BSAVA members).
Meanwhile, the BVA has published the results of its latest Voice of the Profession survey which found that 99% of vets have seen pets in the last 12 months which should have been brought to them for treatment earlier, with 91% reporting that financial reasons were the main factor.
52% of vets also said the number of clients reporting difficulty covering the cost of preventative veterinary care for their animal had increased compared to 2021.
This figure rose to 70% when it came to covering the cost of diagnostic care and treatment.
The Dogs Trust survey, which was carried out by YouGov, asked owners how easy or difficult they would find it to pay vet bills of varying amounts.
10% of pet owners said they would find it fairly difficult to pay unexpected vet bill of £100.
5% said they would find it very difficult.
Overall, 13% said they either cannot afford, or are struggling to afford, the costs of owning a dog in the current climate.
Meanwhile, the charity reports it is getting record numbers of owners asking to hand over their dogs: an average 188 handover requests per day in February compared to an average 141 handover requests per day in 2022, which was itself a record-breaking year (ending in over 50,000 rehoming requests).
In response, Dogs Trust has set up dog food banks at some of its rehoming centres across the UK, which are open to anyone struggling to feed their dog.
The charity has also started a petition asking the Chancellor to Paws the VAT on pet food and veterinary services: https://www.dogstrust.org.uk/support-us/campaigns-appeals/cut-vat-petition
When pet owners were asked in the YouGov survey to what extent they would support or oppose the Chancellor removing VAT from vet care and pet food in next Wednesday’s budget, 61% said they would support it, with 36% of those saying they would strongly support it.
Discuss the value, or not of diagnostics here: https://www.vetsurgeon.org/001/nonclinical/f/life-in-practice-discussions/30519/the-value-or-not-of-diagnostics
www.dogstrust.org.uk
Mr Molnar had been convicted at Manchester and Salford Magistrates’ Court in March 2018 of five counts of importing puppies to the UK in contravention of the Rabies (Importation of Dogs, Cats and other Mammals) Order 1974.
At that court hearing he also pleaded guilty to one count of keeping premises as a pet shop without the authority of a licence granted by a local authority.
As a result of his conviction Mr Molnar was sentenced to 270 hours of unpaid supervised work and was ordered to pay compensation of £2,683.93 and costs of £250.
The Committee, which proceeded with the hearing in Mr Molnar’s absence, found that the RCVS charges against Mr Molnar were proven and went on to consider whether, individually and cumulatively, they resulted in Mr Molnar being unfit to practice being a veterinary surgeon.
Ian Green, chairing the Committee and speaking on its behalf, said: "The Committee accepts the College’s submission that the fact that they [the puppies] were imported contrary to the law of the UK, because they were underage and had not been properly vaccinated, undermines the integrity of a system which is designed to ensure that effective vaccination and precautions against disease take place in every case.
"The Committee also notes that the convictions in this case were directly linked to the respondent’s veterinary practice, as they related to animals sold from his veterinary practice address. By operating an unlicensed pet shop, and by doing so through an email address that referred to his occupation as a veterinary surgeon, the respondent was abusing his position as a veterinary surgeon, and acting in a way that was liable to undermine the reputation of the profession."
The Committee therefore found that, because Mr Molnar’s conviction was directly linked to his veterinary practice and posed a substantial risk to animal welfare and public health, his conviction meant his conduct fell far short of what was expected of a professional.
In considering the sanction for Mr Molnar the Committee considered that, while he had no previous convictions or adverse professional findings against him, the case against him was very serious "because of the risk of serious harm both to animals and the public, as well as being for financial gain."
Ian Green said: "The Committee considered that the respondent, as a veterinary surgeon, must have known the serious implications and consequences of what he was doing by importing these puppies unlawfully. The public should expect to be able to trust a veterinary surgeon to ensure that his conduct does not put at risk the health of both animals and humans."
Mr Green added that the Committee felt that the only appropriate sanction was to direct the Registrar to remove Mr Molnar’s name from the Register.
As a result of the new partnership, customers of Bought By Many will have access to free video consultations with UK-registered veterinary surgeons via the FirstVet app.
In their blurb, the companies say that: "Many common pet health issues can be treated in the comfort of their own home, meaning owners only need to take their pet to the vet when absolutely necessary. Bought By Many customers can save time, money and potential stress to their pet by using the free FirstVet service. When a referral to a local vet is needed, FirstVet provides detailed notes of the initial consultation to both the owner and the vet."
David Prien, FirstVet’s CEO & co-founder, said: "FirstVet couldn't be more excited to offer our veterinary video consultation service together with Bought By Many in the UK.
"From our first meeting with the Bought By Many team, we knew that our values were aligned. We both share a mission to bring the best that technology has to offer both to pet owners and to the veterinary care process.
"Offering pet owners the chance to speak face-to-face with an experienced veterinarian via a video call is a great way to make sure that all pets are getting the right treatment, as fast as possible, in the right location."
For more information on Bought by Many, visit boughtbymany.com/pet-insurance.
Nutrafibre contains high fibre pellets which use a combination of insoluble and soluble plant fibres, probiotic & prebiotics and fish hydrolysate which, the company says, optimises stool consistency and encourages normal bowel movements.
The company claims Nutrafibre also assists anal gland clearance, helps maintain a sufficient level of fibre in the body, supports pets with sensitive digestion, helps reduce hairball in cats and also helps to balance raw and high meat content diets.
Chris Jones, Director at Nutravet said: “We’re incredibly excited to launch this innovative new fibre product.
"The team have worked in partnership with veterinary practices across the UK to create this high fibre supplement and the feedback has been incredibly positive from both vets and pet owners alike.”
For more information, contact: 0845 604 1688, email: info@nutravet.co.uk or visit www.nutravet.com.
Southfields Veterinary Specialists in Laindon, which is part of the Linnaeus Group, has recruited the highly-respected Dr Fabio Stabile to join its neurology and neurosurgery unit.
Fabio will start working at the practice's neurology and neurosurgery unit in January, with another specialist, Dr Ane Uriarte from Tufts University in the USA, joining in the spring.
Fabio said: "I am delighted to be joining Southfields Veterinary Specialists in the new year as a Consultant in neurology and neurosurgery.
"It is an extremely exciting time to be joining Southfields and their team of renowned and successful specialists, especially as this is a strong time of growth in their neurology/neurosurgery discipline.
"The imminent move of the Southfields team to a new, state-of-the-art hospital with the possibility of creating a new phenomenal environment and ‘family’ is really exciting!"
Fabio graduated from Padova University in 2003 before completing a three-year PhD in veterinary clinical sciences at the university supervised by Dr Marco Bernardini DVM, DECVN.
In 2009, he moved to the UK and started a Residency in Neurology and Neurosurgery at the Animal Health Trust under the supervision of Dr Luisa De Risio DVM, FRCVS, PhD, DECVN.
Fabio added: "My main area of interest in veterinary neurology and neurosurgery are epilepsies and the treatment of epilepsy and any neurosurgeries.
"Improving antiepileptic treatment for our patients has constituted my main focus of clinical research. It’s a subject I strongly care about."
Dr Stabile also enjoys passing on the benefits of his expertise and experience to the next generation of veterinary surgeons. He has presented several clinical research abstracts at international and European conferences and he is the author of multiple publications in peer reviewed journal Veterinary Services.
"I have always been extremely keen on teaching and I enjoy delivering lectures to young colleagues in training and to colleagues working in general practice."
Ceva Animal Health has announced the launch of Cardalis for the treatment of canine heart failure caused by degenerative valvular heart disease.
Cardalis contains what the company says is a unique combination of benazepril and spironolactone in one tablet which provides "dual blockade" of the RAAS system.
Benazepril reduces the production of angiotensin II, which causes narrowing of the blood vessels, while spironolactone blocks the harmful effects of aldosterone, which include cardiovascular remodelling and fibrosis.
Cardalis tablets are small, beef flavoured and designed to be administered once a day with food. Each pot contains 30 tablets and there are three sizes available. Ceva says it should be given as part of standard heart failure therapy as soon as clinical signs, such as exercise intolerance, coughing or dyspnoea, appear.
Fraser Broadfoot, small animal product manager at Ceva Animal Health, said: "Through our clinical studies, it has been found that dogs receiving benazepril and spironolactone (compared with benazepril alone) have a better quality of life and, at any one time, are three times less likely to die from heart failure.
"We have also assessed 101 dogs in a field study that were prescribed Cardalis for three months, followed by separate benazepril and spironolactone tablets for two weeks. In the study, 97 per cent of dog owners found Cardalis easier to administer than the two separate tablets and 89 per cent of vets found Cardalis easier to prescribe."
For further information about Cardalis, or to receive marketing materials for the product (which include a waiting room poster and client information booklets), visit www.ceva.com.uk, or contact the practice support team on 01494 781510.
The company says it has made the test available in response to customer demand and growing evidence that in rare cases pets living with COVID-19-positive humans can be at risk of infection.
The test will be available to veterinary surgeons in North America this week and will roll out across most of the world in the coming weeks, via the company's worldwide network of laboratories.
Jay Mazelsky, President and Chief Executive Officer of Idexx Laboratories said: "We have continued to monitor the rapidly evolving public health crisis worldwide, paying special attention to the effects on pets.
"While there is currently no evidence that dogs or cats play a role in transmitting the disease to humans, it became clear offering the test was the right thing to do when we saw clinical evidence that pets—especially cats and ferrets—can in rare cases be at risk for infection. And, we heard from our customers around the globe that veterinarians needed a testing option."
Idexx recommends the test is used when three specific criteria are met:
Idexx says leading health authorities agree with the company that transmission of the SARS-CoV-2 virus is primarily person-to-person and advise against testing asymptomatic pets. Since mid-February, the company has tested over 5,000 specimens for the virus, from cats, dogs, and horses with respiratory symptoms in 17 countries. To date, it has found no positive results, suggesting that dogs and cats living with infected people generally remain uninfected, except in rare and isolated cases.
For information about the Idexx SARS-CoV-2 (COVID-19) RealPCR Test for pets, visit idexx.com/covid19-pet-test.
The new study, which was conducted by the RVC's VetCompass Programme found that 33% of deaths in dogs aged under 3 years (roughly 21,000 dog deaths in the UK) are caused by undesirable behaviours which may reflect poor training by owners, or be caused by undiagnosed medical conditions.
The study also found that male dogs and smaller dogs were more likely to die from undesirable behaviours than female or larger dogs and that certain breeds were hugely predisposed.
It is hoped that this research can raise awareness of the most common undesirable behaviours in dogs and encourage owners to improve the health and welfare of their animals through better choices when getting a puppy and improved training afterwards.
The RVC conducted this study using its analytics programme, VetCompass, to explore the de-identified data of a quarter of a million dogs in the UK.
From this data, the researchers identified 1,574 dogs that had died before the age of 3 years.
Analysing the patterns of deaths, they found that:
33.7% of all deaths in dogs (or roughly 21,000) aged under 3 years in the UK are due to undesirable behaviours
The most common undesirable behaviours that led to death were aggression (54.0% of deaths) and road traffic accident [which may have behavioural components such as straying and poor recall] (39.0% of deaths).
Crossbred dogs were 1.4 times more likely to die from an undesirable behaviour than purebred dogs.
Dogs weighing under 10 kg were more than twice as likely to die from an undesirable behaviour as dogs weighing over 40 kg.
Compared with the Labrador Retriever, the breeds with the highest risk of death from an undesirable behaviour were the Cocker Spaniel (8 times the risk), West Highland White Terrier (5.7 times the risk), Staffordshire Bull Terrier (4.5 times the risk), and Jack Russell Terrier (2.7 times the risk). The Labrador Retriever was chosen as the baseline breed as it is a common and well-known breed.
Male dogs were 1.4 times more likely to die from an undesirable behaviour than females.
Of the dogs that died from an undesirable behaviour, the owners of 12.9% dogs had sought veterinary behavioural advice.
Behavioural drug therapy was used in 3% of dogs that died from an undesirable behaviour.
12.2% of dogs that died from an undesirable behaviour had been previously rehomed.
76.2% of the dogs that died from an undesirable behaviour were euthanised (i.e. put to sleep).
The paper raises severe concerns about the high numbers of dogs that are put to sleep due to undesirable behaviours which accounts for over three-quarters of all dogs that die from undesirable behaviours.
Dr. Dan O'Neill, Senior Lecturer at the RVC and supervisor of the study, said: "This study is the biggest study ever undertaken on behavioural reasons for deaths in young dogs in the UK.
"It suggests the importance of good socialisation of puppies by breeders, of sensible breed selection by owners and of careful dog training after acquiring a dog, to ensure that the lives of dogs and owners are fulfilling for all parties involved.
"Dogs with behaviours that their owners find unacceptable are at risk of compromised welfare, either because of their own underlying emotional motivations for the behaviour (e.g. anxiety or fear) or because of how their owners might seek to resolve the problem (e.g. the use of punishment such as beating or electric shock collars).
"Greater awareness of the scale of this issue can be the first step towards reducing the problems and making the lives of thousands of our young dogs happier."
Tim Harrison, managing director at White Cross Vets, said: "Our plan has been to open five new practices within a 12 month period and despite having a strong presence in West Yorkshire we didn’t have a practice in South Yorkshire. When we found out Dave wanted to move to Sheffield it made perfect sense for us to expand into the area and for him to lead the practice as clinic director.
"Dave is a hugely talented and compassionate professional and we certainly didn’t want to lose him. The Handsworth opening is the perfect fit for Dave who will lead a team of four. As the practice expands, we envisage that we will create a further 20 jobs over the next five years.”
White Cross says it has invested £250,000 in the practice, which is opening on the site of a former sausage factory which has recently been redeveloped at a cost of £1.1M.
Dave said: "I was so thrilled when Tim told me his plans for Sheffield. I love the area and my wife’s family have grown up there, I have been wanting to set up a long term family home for a while, and the fact that I have been able to move my young family to South Yorkshire, and still work for White Cross Vets, makes me really happy."
The pads contain ophytrium and chlorhexidine at 3%. Ophytrium is a purified natural ingredient from Ophiopogon japonicus which, Ceva says, strengthens the mechanical skin barrier1, restores the balance of protective microbial flora2 and reduces irritation, while soothing the skin1. Chlorhexidine is both antibacterial and antifungal.
Ceva says that Douxo S3 Pyo pads, which come in packs of 30, provide antibacterial and antifungal efficacy within one minute and are free from soap, parabens, sulphates, phthalates, colourants and nanoparticles.
They are available in a new, hypoallergenic ‘summertime’ fragrance which pet owners liken to coconut and vanilla.
The pads add to the Douxo S3 Pyo range, which also consists of shampoo and a mousse.
Andrew Fullerton BVSc (Hons) MRCVS, product manager for Douxo S3 at Ceva said: "The new Douxo S3 range has been well received by both veterinary professionals and their clients since its launch, who find that the products are not only effective and well tolerated, but also easy-to-use. The Douxo S3 Pyo pads will enhance this range by offering an easy-to-administer antiseptic action while hydrating and maintaining the skin’s ecosystem.”
For further information, contact cevauk@ceva.com, your local territory manager or visit https://www.douxo.com/uk/Pet-Skin-Care/douxo-s3.
References
Dr Bremner was convicted in 2017 of harassing his ex-wife, and for perverting the course of justice by sending his daughter an e-mail, pressuring her to ask her mother to withdraw the charges against him. He pleaded guilty to both of the charges, saying he did not understand that it was a condition of his bail that he could not contact his ex-wife. He also expressed shame and remorse at his actions, explaining that his behaviour was triggered by extreme anger, grief and stress.
In relation to the charges, the Respondent was committed to prison for 12 months, suspended for 12 months, ordered to comply with a Rehabilitation Activity Requirement within 12 months, and ordered to pay £85 in costs and £115 as a surcharge to pay for victim services.
The Committee found the facts proved based on the certified copy of the certificate of conviction, as well as the Respondent’s admissions to the facts of the charges. It was satisfied that the Respondent brought the profession into disrepute by the seriousness of his convictions. In addition, the Committee regarded the Respondent as having deficient insight and a need to fully accept personal responsibility for his actions and their consequences.
The Committee was also satisfied that the nature of the communications sent by the Respondent which led to the convictions and the breach of bail conditions, coupled with deficient insight amounted to serious professional misconduct and rendered him unfit to practise veterinary surgery.
The Committee considered various mitigating factors including the fact that no actual harm occurred to any animal, there were no concerns raised about the respondent’s practice, that he has a long and unblemished career, and that he showed some insight into his offences which continues to develop.
The Committee also took into account that preventing the Respondent from practicing could mean the loss of jobs for 33 or so employees, which weighed heavily on their decision. The Committee also agreed with the RCVS’s submissions that there was a very low likelihood of repetition of the offending behaviour. Aggravating factors included the emotional harm caused to the Respondent’s ex-wife, and that the harassment was a course of conduct sustained over a period of five months.
Therefore, when taking into account the particulars of this case, the Committee decided to impose a reprimand and warning on the basis that it would be proportionate to maintain public confidence in the profession in light of the serious nature of these charges.
Chitra Karve, chairing the Committee and speaking on its behalf, said: "The Committee was of the view that the conviction for intending to interfere with the course of justice was particularly serious, in light of the need to maintain public confidence in the profession, because it involved a disregard of proper criminal process.
"However, a particular feature of this case is the risk to the jobs of 33 or so employees if the Respondent were to be prevented from practising as a result of the Committee’s imposition of a sanction. It is this mitigating factor which weighed most heavily with the committee and they therefore concluded that both a Reprimand as to this conduct and a Warning as to any future conduct is sufficient and proportionate in this case to meet the need to maintain public confidence in the profession and uphold proper standards."
Mr Bremner has 28 days in which to make an appeal about the Committee’s decision to the Privy Council.
The Mercury Challenge, which is being conducted by Ceva Animal Health, aims to collect data on 10,000 cats across Europe to provide a new insight into the detection and management of feline hypertension, a frequent and severe condition that is still not routinely checked1.
Vets participating in the initiative need to input five mandatory pieces of information at mercurychallenge.ceva.com: the owner’s name, cat’s name, age, systolic blood pressure and time spent measuring blood pressure. Additional information includes: weight, breed, sex and whether the animal has any concurrent diseases, such as chronic kidney disease or hyperthyroidism, or is on any treatments.
Participating practices will be given exclusive access to the study’s progression and results, as well as acknowledgements for their contribution to the Mercury Challenge, depending on the number of cats entered.
Imane Mahlous, cardiology-nephrology and hypertension product manager at Ceva Animal Health said: "It is quick and easy to take part in the Mercury Challenge, which we hope will revolutionise the way that feline hypertension is understood and treated by both cat owners and veterinary professionals."
For information on feline hypertension or the Mercury Challenge, contact your local Ceva Animal Health account manager or visit mercurychallenge.ceva.com.
Alexander Reiter and Margherita Gracis formed the new editorial team and selected an international collection of leaders in their fields of expertise to contribute to this latest edition.
Alexander said: "This is a timely publication, as veterinary dentistry is a field that continues to grow in importance for the general veterinary practitioner. We found it important to add 'Oral Surgery' to this new edition, as many procedures performed in and around the mouth involve surgical techniques."
The BSAVA Manual of Canine and Feline Dentistry and Oral Surgery, 4th edition, is an accessible source of core information for general small animal veterinary surgeons, nurses/technicians and students interested in developing their theoretical knowledge and practical skills in dentistry and oral surgery.
The manual is now available from the BSAVA website (www.bsava.com/shop), the BSAVA Library (www.bsavalibrary.com/manuals), or by phone: 01452 726700.
Mr Seymour-Hamilton was originally removed from the Register following an inspection of his Kent practice in 1993 which found that his operating theatre “showed a total disregard of basic hygiene and care for animals and was such as to bring the profession into disrepute”.
Since being removed from the Register, Mr Seymour-Hamilton has made applications for restoration in 1995, 2010, 2015, 2016, 2017, 2018 and 2019. Each was rejected.
In his latest application, Mr Seymour-Hamilton said that he did not want to re-join the Register in order to practise but to facilitate his research in the area of herbal medicine.
The Committee found that while Mr Seymour-Hamilton had accepted some of the findings of the original case, he disagreed with important facts, such as whether or not his surgery was open at the time of the inspection, and showed ‘minimal insight’ into the seriousness of the findings.
The Committee also voiced concerns over public protection and animal welfare should he be restored, saying that he had demonstrated little or no understanding of the purpose of regulation. The Committee also noted that he had, by his own admission, spayed two cats at a practice in Calais in recent years despite his long absence from the Register and unregistered status as a veterinary surgeon in the UK or France.
In considering his conduct since leaving the Register, the Committee found that Mr Seymour-Hamilton had admitted to a number of instances of conduct which it found ‘reprehensible’. This included carrying out spays; not self-isolating after testing positively for coronavirus and, in fact, travelling through France and Spain in breach of the lockdown put in place due to the pandemic; deliberately trying to re-infect himself with coronavirus and then visiting a vulnerable person without maintaining social distancing; treating his own animals with untested herbal remedies; and using his own remedies to treat people, which, in one case, included a nine-year-old boy in Greece.
In summing up Judith Way, who was chairing the Committee and speaking on its behalf, said: “The Committee has concluded that he has not satisfied it that he is fit to be restored to the Register. He has exhibited a disregard for regulation and compliance with the law. He lacks an understanding as to why he has not been restored in the past. He has not set about addressing any of his shortcomings. He relies wholeheartedly on his research, yet he does not support that research with any real peer-reviewed publications and he fails to acknowledge the consequences of being out-of-practice for so long. He has misplaced confidence in his own abilities and does not recognise that his approach and/or actions can represent a danger to animals and to the public. The Committee has therefore reached the conclusion that the applicant is not a fit person to be restored to the Register.”
The full findings of the restoration hearing for Mr Seymour-Hamilton can be found at: www.rcvs.org.uk/disciplinary
A group of brave veterinary nurses and a student nurse leapt out of a perfectly serviceable aircraft last weekend, both to raise money for children with epilepsy, and to highlight the need to protect the title 'Veterinary Nurse' in law.
Vicky Couzens, Jenny Cook, Kim Blowing, Michelle Dickens, Gillian James and Leigh Martin, none of whom had parachuted before (in fact, Gillian hadn't even been in a plane before), were raising money for the Muir Maxwell Trust, a charity which funds research into childhood epilepsy, and supports the families of some of the 70,000 children affected by it in the UK.
The daredevil nurses also wanted to highlight the fact that anyone can call themselves a veterinary nurse, regardless of whether they've ever even set foot inside a veterinary practice, let alone passed the demanding examinations. They argue that the title 'Veterinary Nurse' should be protected in law, in exactly the same way as 'Veterinary Surgeon', so that the pet-owning public can have the reassurance of knowing when their animal is being cared for by a qualified professional.
To support these nurses' efforts, and help them reach their fundraising targets, click the links below:
http://www.justgiving.com/Victoria-Couzens http://www.justgiving.com/Jenny-Cook23 http://www.justgiving.com/KimBlowing http://www.justgiving.com/Michelle-Dickens
Meanwhile, one of the children that has benefitted from the work done by the Muir Maxwell Trust is Emily Guthrie, daughter of the editor of VetNurse.co.uk and VetSurgeon.org. She sent the jumpers her own message of thanks:
The Royal College of Veterinary Surgeons has announced the results of the 2011 RCVS and VN Council elections.
Elected to the RCVS Council are:
Not elected are:
For the first time in eight years, all six successful RCVS Council candidates have served on Council before, although one - Sandy Trees - is currently an appointed, rather than an elected, member.
For VN Council, one existing member has been returned and two new members have been elected:
Not elected to VN Council was:
Following rises in previous turnouts, voting figures have dropped markedly this year in both RCVS and VN Councils elections, to 15.9% (3,887 voters) and 7.6% (723 voters) respectively. The previous turnouts were 18.8% (in 2010) and 11.2% (in 2009).
RCVS Registrar Jane Hern said: "It's certainly disappointing that the turnout has dropped so much this year. It's unclear whether this is due to lack of time, lack of awareness, or lack of interest, but perhaps anyone who didn't vote could let us know why, so we can see what we could do to increase participation.
"Nevertheless, my congratulations to all successful candidates, who I look forward to formally welcoming, or welcoming back, onto the Councils at RCVS Day in July, and my commiserations to those who were unsuccessful this time and who I hope won't be discouraged from standing again next year."
This year's chosen charity - the Veterinary Benevolent Fund - will receive a cheque for £922 arising from the College's pledge to donate 20p for each veterinary surgeon and veterinary nurse who cast a vote.
The company says it has redesigned the packaging to make it more distinctive, the idea being that it makes stock control in the practice and vaccine management on the farm easier and it also makes it easier for veterinary surgeons to identify and grab the right product off the shelf.
The new, bright red packaging for Bovilis IBR Marker Live is shown right. What do you think? Comment below.
Ceva Animal Health has launched Hepatosyl Plus, a development of the liver support supplement for cats and dogs.
Hepatosyl Plus contains the same ingredients as the original product but now also includes Silybin. According to the company, Silybin is the most active isomer of Silybum marianum (milk thistle) which acts as an antioxidant by increasing cellular superoxide dismutase. It joins S-adenosylmethionine (SAMe) and Vitamin E to create a triple antioxidant approach to liver support, helping to neutralise free radicals within the liver. Ceva also says Hepatosyl Plus is the only liver supplement to contain Vitamin K, which is needed by the liver for the production of clotting factors II, VII, IX and X, making it ideally suited for pre- and post-anaesthetic liver support.
Hepatosyl Plus is available in 50mg, 100mg and 200mg sprinkle capsules. For anaesthetic support, Hepatosyl Plus should be administered for one week prior to and following anaesthesia. For long-term use, the capsules should be given once daily for 2-3 months and then reduced to every other day for ongoing maintenance.
For further information, please contact your local CEVA Animal Health territory manager or call 01494 781510.
Norbrook Laboratories has launched a ready-to-use suspension version of its Cefenil antibiotic.
Cefenil RTU (ceftiofur) is a 50mg/ml suspension for injection, indicated for cattle and swine.
Dr Barry McInerney, Norbrook's GB Veterinary Advisor said: "Cefenil RTU is a broad spectrum injectable antibiotic offering fast and effective treatment of bacterial respiratory disease, foot rot and acute post-partum metritis in cattle as well as bacterial respiratory disease in swine. It offers a zero milk withhold and a 5-day meat withhold which is the shortest on the market."
Norbrook's Cefenil Powder and Solution for Injection has been available for a number of years for the treatment of cattle and swine. It has recently been indicated for the treatment of BRD in horses in the UK. Cefenil RTU will offer vets an additional choice in the treatment of BRD.
Dr McInerney added: "Cefenil is a tried and tested antibiotic which vets have been using for a number of years. We are delighted to extend the Cefenil range with a RTU suspension for cattle and pigs and adding an indication for horses to our Cefenil Powder and Solution for Injection. It gives vets a wider choice for the treatment of BRD with a product with which they are already familiar."
For further product information, visit www.norbrook.com.
The researchers say that ultimately the study should help with the development of guidelines to help all riders assess if they are the right weight for the horse or pony they intend to ride, to enhance both equine welfare and rider comfort and enjoyment.1
Dr Sue Dyson, Head of Clinical Orthopaedics at the Animal Health Trust’s Centre for Equine Studies, Newmarket, who led the study said: "While all the horses finished the study moving as well as when they started, the results showed a substantial temporary effect of rider weight as a proportion of horse weight.
"The results do not mean that heavy riders should not ride but suggest that if they do they should ride a horse of appropriate size and fitness, with a saddle that is correctly fitted for both horse and rider.
"We must remember that this is a pilot study: further work is required to determine if horse fitness, adaptation to heavier weights and more ideal saddle fit will increase the weight an individual horse can carry. This should help us further in our quest to develop guidelines for optimum rider: horse bodyweight ratios."
As the average weight and height of humans continues to increase there is growing debate about relative rider-horse sizes, with riding school horses epitomising the variety of weights of rider that a single horse may be exposed to.
Numerous inter-related aspects are involved with the horse and rider combination including the age of the horse, its fitness and muscle development, the length of its back and the presence or absence of lameness. The rider’s skill, fitness, balance and coordination are important factors, as is the fit of the saddle to both the horse and rider. The type, speed and duration of work and the terrain over which the horse is ridden must also be considered.2
To date little research has been conducted on the effects of rider weight on equine welfare and performance. To address the shortfall World Horse Welfare, the Saddle Research Trust, the British Equestrian Federation and a number of other organisations helped to fund a pilot study last summer, the results of which have now been analysed.
The influence of rider to horse bodyweight ratios on equine gait and behaviour: a pilot study1 assessed gait and behavioural responses in six horses ridden by four riders of similar ability but different sizes. The riders were all weighed in their riding kit and were subsequently categorised as being light, moderate, heavy and very heavy. Their body mass index (BMI) was also calculated.
Each rider rode each horse in its usual tack and performed a set pattern of exercises comprising mainly trot and canter. Gait, horse behaviour, forces under the saddle, the response to palpation of the back, alterations in back dimensions in response to exercise, heart and respiratory rates, salivary cortisol levels and blink rate were assessed for each combination.
The riding tests for the heavy and very heavy riders were all abandoned, predominantly because of temporary horse lameness. This was likely to have been induced by bodyweight rather than BMI, given that the heavy and moderate riders had similar BMIs, both being classified as overweight, yet only one of the moderate rider’s tests had to be abandoned. An ethogram, developed by Dr Dyson specifically to assess behavioural markers which may reflect pain in ridden horses3, was applied. The scores which may reflect pain were significantly higher in the horses when ridden by the heavy and very heavy riders.
The study also raised the issue of rider height and saddle fit. The owner of one of the test horses had a similar bodyweight: horse bodyweight ratio to the heavy rider and was of similar weight, but significantly different in height (157.0 and 185.5 cm, respectively). This large difference in height has major potential implications for saddle fit for the rider and consequently the rider’s position and weight distribution. The taller rider sat on the back of the cantle, overloading the back of the saddle and making it more difficult to ride in balance, with the heel being in front of a vertical line between the shoulder and ‘hip’.
Roly Owers, Chief Executive of World Horse Welfare, said: "These pilot results are certainly not surprising but are very significant in adding vital evidence to inform an appropriate rider: horse weight ratio. It is common sense that rider weight impacts equine welfare however many might not fully understand or recognise this. What is desperately needed is basic guidance to help riders identify a horse or pony that is right for them and this research is a vital step in that direction.”
The study was generously supported by World Horse Welfare, the Saddle Research Trust, Frank Dyson, British Equestrian Federation, British Horse Society, Pony Club, Polocross, The Showing Council, The Showing Register, The Society of Master Saddlers, Riding for the Disabled, British Eventing, British Dressage, the British Horse Foundation, the Worshipful Company of Saddlers and Endurance GB.
Chanelle's head of sales and marketing, Killian Gaffney said: "The total UK market is around 80,000 bottles annually. However, with the major supplier announcing some re-stocking in March but full availability still under question, there is a real sense of urgency for practitioners.
"The Chanelle team worked throughout December with our manufacturing division to ensure that the UK product shortfall could be alleviated.
"Air freighting supplies seemed the obvious course of action, and ensured we could supply the UK market as quickly as possible."
For further information, contact: Chanelle on 00353 91 841 788.
Dechra says phenobarbital is effective as a monotherapy in 60 to 80 per cent of dogs with idiopathic epilepsy, but that in 40% of dogs, seizures cannot be controlled with phenobarbital alone. In these cases the company's potassium bromide treatment Libromide, is licensed to be used alongside Soliphen as a concurrent therapy.
According to the company, the combination of phenobarbital and potassium bromide has been shown to reduce seizure number and severity in dogs with refractory idiopathic epilepsy; in tests, the combination treatment reduced the mean seizure rate from 27.4 seizures per month to 2.2 seizures.
Dechra Veterinary Products Brand Manager Craig Sankey said: "Epilepsy is the most common chronic canine neurological disorder, affecting around 0.62 per cent of dogs.
"It can be a distressing condition for both the animal and its owner so we are launching a therapy that can reduce the number of seizures in even the most challenging cases.
"We have also produced new guidelines for prescribing vets, detailing step by step how the treatments can act alone or concurrently. We believe using Soliphen as a sole therapy or in conjunction with Libromide will make a positive contribution to veterinary professionals in their ongoing treatment and management of dogs with epilepsy."
For more information, visit www.dechra.co.uk